CLINDAMYCIN 600 MG/4 ml Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
CLINDAMYCIN 600 MG/4 ml Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Lincosamide Antibiotic (Parenteral)
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our CLINDAMYCIN 600 MG/4 ml Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following CLINDAMYCIN 600 MG/4 ml Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
CLINDAMYCIN 600 MG/4 ml Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our CLINDAMYCIN 600 MG/4 ml formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Severe MRSA skin and soft-tissue infections
- Necrotising fasciitis (with beta-lactam)
- Toxic shock syndrome
- Severe intra-abdominal and pelvic anaerobic infections
- Septic arthritis and osteomyelitis
- Aspiration pneumonia with anaerobic component
Mechanism of Action
Same as oral clindamycin — 50S ribosomal subunit binding, protein synthesis inhibition, plus exotoxin suppression.
Dosage & Administration
- Adults: 600–900 mg every 8 hours by slow IV infusion or IM.
- Strictly hospital use.
- Step down to oral when clinical improvement allows.
Side Effects
- Infusion-site pain, phlebitis.
- Diarrhoea (including C.
- difficile colitis), nausea, rash.
- Rare: pseudomembranous colitis, hepatotoxicity, hypersensitivity.
Contraindications
- Hypersensitivity to lincosamides.
- History of C.
- difficile colitis.
- Severe hepatic impairment.
Storage
Store below 25 °C in a dry place, protected from light. Do not freeze.
PCD Pharma Franchise for CLINDAMYCIN 600 MG/4 ml Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 4ml with monocarton
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for CLINDAMYCIN 600 MG/4 ml Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of CLINDAMYCIN 600 MG/4 ml Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of CLINDAMYCIN 600 MG/4 ml Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of CLINDAMYCIN 600 MG/4 ml Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is CLINDAMYCIN 600 MG/4 ml Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer CLINDAMYCIN 600 MG/4 ml Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for CLINDAMYCIN 600 MG/4 ml Tablet?
Available pack sizes include: 4ml with monocarton.
What is the MRP / trade price for CLINDAMYCIN 600 MG/4 ml Tablet?
MRPs range from ₹254 to ₹254 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for CLINDAMYCIN 600 MG/4 ml Tablet?